Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates if a report of a patient with a serious side effect is linked to the shot.In a statement issued Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data.”AstraZeneca didn’t reveal any information about the possible side effect except to